Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects gave the complaint of Asragdara with any two of the following features for 2 consecutive cycles. Heavy menstrual bleeding (amount Greater than 80ml) (Amount more than 80 ml will be assessed by pictorial blood loss assessment chart scoring more than 100 points.) Prolonged menstrual bleeding Greater than 7 days. Inter menstrual bleeding with/without heavy flow or Frequent menstrual cycle less than 24days. Features different from normal menstrual blood, pain, burning sensation, body ache.
Exclusion criteria
Exclusion criteria: Patients with chronic of systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, Tuberculosis endometritis, severe anemia, chronic renal disease, Insulin dependent diabetes mellitus etc.). Patients using Intrauterine contraceptive device or oral contraceptive pills (latrogenic). Patients with uterine and pelvic pathology (Fibroid size Greater than 2 cm, endometriosis, adenomyosis, polyp, high grade cervical erosion, endometrial thickness Greater than 20mm etc.). Benign and malignant growth. Thyroid dysfunction (endocrinal disorders). Patients having bleeding due to abortion, ectopic pregnancy, during puerperium. Patients taking Anti-coagulation therapy and having hematological disorders (Leukemia, Thrombocytopenic Purpura). Postmenopausal bleeding. Sexually transmitted infections/Genital tract infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in symptoms of AsragdaraTimepoint: Change in the symptoms of Asragdara from baseline to 2 months of period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in PBLAC scoring system.Timepoint: Changes in PBLAC scoring system from baseline to 2 months of period. | — |
Countries
India
Contacts
National Institute Of Ayurved